Who founded Path EX, Inc.?

Path EX, Inc. was founded by Sindead Miller.

Who are Path EX, Inc.'s investors?

Path EX, Inc.'s investors include Houston Angel Network, Innova Memphis, Inc., Texas HALO Fund, TMC Venture Fund, Fitz Gate Ventures.

How much funding has Path EX, Inc. raised?

Path EX, Inc. has disclosed $8.3M raised across 2 rounds.

Where is Path EX, Inc. headquartered?

Path EX, Inc. is headquartered in Houston, US.

Path EX, Inc.

Houston, US · Delaware corporation · 5 known investors

pathex.co ↗

BiotechHealthtech

Founders & leadership

Sindead MillerFounder

Alex WieselerExecutive

Board

Ehsan JabbarzadehBoard director

Jeffrey BurbankBoard director

Investors · 5

Houston Angel NetworkHouston

Innova Memphis, Inc.Memphis · $2M

Texas HALO FundHouston

TMC Venture FundHouston

Fitz Gate VenturesreportedHouston · $500K – $1M

Competitors · 1

by search overlap

ARTHEx Biotech’s website4 shared keywordsArthex Biotech develops an investigational anti-miR therapeutic targeting an upregulated miRNA for the treatment of myotonic dystrophy, aiming to address the root cause of the disease. Its lead program uses an oligonucleotide conjugated to a fatty acid to improve delivery to muscle tissue at low active doses.

Companies competing with Path EX, Inc. for the same Google search keywords, organic and paid, via search-intersection analysis.

Reported raises · per SEC filings

Form D private placements

$8.3M disclosed across 2 rounds · 2017–2025

▶$8.2MraisedMay 2025 · 14 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Sindead MillerExecutive Officer, Director
Ehsan JabbarzadehDirector
Jeffrey BurbankDirector

Offering amount: $8.2M
Amount sold: $8.2M
First sale: Apr 2025
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$100KraisedMay 2017 · 2 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Sinead MillerExecutive Officer, Director
Alex WieselerExecutive Officer, Director

Offering amount: $100K
Amount sold: $100K
First sale: May 2017
Incorporated: Corporation, Delaware, 2017
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken

Agency	Phase	Year	Amount
National Science Foundation	Phase II	2018	$750K
National Science Foundation	Phase ISTTR	2017	$225K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

Who founded Path EX, Inc.?: Path EX, Inc. was founded by Sindead Miller.
Who are Path EX, Inc.'s investors?: Path EX, Inc.'s investors include Houston Angel Network, Innova Memphis, Inc., Texas HALO Fund, TMC Venture Fund, Fitz Gate Ventures.
How much funding has Path EX, Inc. raised?: Path EX, Inc. has disclosed $8.3M raised across 2 rounds.
Where is Path EX, Inc. headquartered?: Path EX, Inc. is headquartered in Houston, US.